These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10128611)

  • 1. Drug-usage evaluation: traditional versus outcome-based approaches.
    Kier KL; Pathak DS
    Top Hosp Pharm Manage; 1991 Apr; 11(1):9-15. PubMed ID: 10128611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizing for drug-usage evaluation.
    Buchanan C; Sands P
    Top Hosp Pharm Manage; 1991 Apr; 11(1):16-37. PubMed ID: 10128604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using drug-usage evaluation to improve drug use.
    Conrad WF; Armistead JA
    Top Hosp Pharm Manage; 1991 Apr; 11(1):1-8. PubMed ID: 10128603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care.
    Angaran DM
    Am J Hosp Pharm; 1991 Sep; 48(9):1901-7. PubMed ID: 1928130
    [No Abstract]   [Full Text] [Related]  

  • 5. A simplistic approach to establishing drug usage/quality assurance programs.
    Adachi W
    Hosp Pharm; 1990 Jun; 25(6):541-4, 546-50, 555-9. PubMed ID: 10104830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborating with physicians in the drug-usage evaluation process.
    Phillips MS
    Top Hosp Pharm Manage; 1991 Apr; 11(1):38-45. PubMed ID: 10128605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting, developing, and evaluating indicators.
    Angaran DM
    Am J Hosp Pharm; 1991 Sep; 48(9):1931-7. PubMed ID: 1928135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revising a drug information center quality assurance program to conform to Joint Commission standards.
    Moody ML
    Am J Hosp Pharm; 1990 Apr; 47(4):792-4. PubMed ID: 2321654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model drug usage evaluation program.
    Bunting RF
    J Qual Assur; 1990; 12(3):30-3, 50. PubMed ID: 10105582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-usage evaluation and the patient-care pharmacist: a synergistic combination.
    Gayman J; Tapley DJ
    Top Hosp Pharm Manage; 1991 Jul; 11(2):31-43. PubMed ID: 10128633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug usage evaluation: perspectives and reappraisal.
    Loomis JH; Van Mouwerik TJ; Schillaci LJ
    Top Hosp Pharm Manage; 1988 Feb; 7(4):79-95. PubMed ID: 10314269
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality and outcome: pharmacy's professional imperative.
    Enright SM; Flagstad MS
    Am J Hosp Pharm; 1991 Sep; 48(9):1908-11. PubMed ID: 1928131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of generic screening criteria for clinical interventions that link prescribing to credentialing.
    Mustion AL; Sobotka J
    Hosp Pharm; 1991 Nov; 26(11):968-72, 1015. PubMed ID: 10114824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing patient outcomes.
    Enright SM
    Am J Hosp Pharm; 1988 Jun; 45(6):1376-8. PubMed ID: 3166341
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives on pharmacy and quality assurance--a talk with Jim Grogan.
    Grogan J
    Top Hosp Pharm Manage; 1981 Nov; 1(3):91-9. PubMed ID: 10313957
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-usage evaluation: a system for the prospective evaluation of antibiotic utilization in minimum inhibitory concentration documented infections.
    Sharp WT; Driver P; Bartlome P
    Top Hosp Pharm Manage; 1991 Jul; 11(2):59-69. PubMed ID: 10128636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality measurement for health systems: accreditation and report cards.
    O'Malley C
    Am J Health Syst Pharm; 1997 Jul; 54(13):1528-35. PubMed ID: 9217945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Documenting concurrent clinical pharmacy interventions.
    Haslett TM; Kay BG; Weissfellner H
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.